Caren van Roekel

190 Chapter 7 TABLE 1. Baseline patient and treatment characteristics Characteristic N (%) or median + range Gender Male 25 (62.5) Female 15 (37.5) Age (y) 64 (37-84) WHO performance score 0 28 (70) 1 11 (27.5) 2 1 (2.5) Previous therapy* Locoregional (liver) EBRT 2 (5) Metastasectomy 5 (12.5) Radiofrequency ablation 3 (7.5) Lines of prior systemic treatment 1 8 (20) 2 20 (50) 3 7 (17.5) 4 5 (12.5) Extrahepatic disease before treatment Lymph node 10 (25) Lung 10 (25) No 23 (57.5) Liver volume (mL) 1987 (1272-3167) Metabolic tumor volume (mL) 320 (26-1446) Fractional tumorload 0.15 (0.01-0.49) Radioembolization treatment Whole-liver 39 (97.5) Lobar (right lobe only) 1 (2.5) Administered activity (MBq) 6387 (3822-12386) *No patient received synchronous systemic treatment.